hydroxychloroquine
Hydroxychloroquine is a drug used to treat COVID-19, Rheumatoid Arthritis, Corona Virus Infection, and other conditions. Hydroxychloroquine is being actively studied in 97 studies and prior, has been studied in 79.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Abramson Cancer Center of the University of Pennsylvania | Abramson Cancer Center of the University of Pennsylvania | Seyed Sina Naghibi Irvani, MD, MPH, MBA, Senior Researcher. |
| Rutgers, The State University of New Jersey | Rutgers Cancer Institute of New Jersey | Abdelrahman Mahmoud Mohammed |
| Assiut University | Massachusetts General Hospital | Daniel H. Solomon, M.D.,MPH |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Active, not recruiting
- Hydroxychloroquine
- Hydroxychloroquine
- +3 more
- Assiut, EgyptAbdel-rahman Mahmoud Mohammed
2021-07-21
Jul 21, 2021A
Recruiting
- Hydroxychloroquine
- Hydroxychloroquine
- +3 more
- Assiut, EgyptAbdel-rahman Mahmoud Mohammed
2021-07-21
Jul 21, 2021W
Suspended
- Type 2 Diabetes Mellitus
- Hydroxychloroquine
- Hydroxychloroquine Placebo
- Saint Louis, MissouriWashington University
2021-06-03
Jun 3, 2021H
Terminated
- Coronavirus Infection
- Nitazoxanide 500 MG
- Hydroxychloroquine
- Toluca, MexicoMaterno-Perinatal Hospital "Mónica Pretelini"
2021-03-29
Mar 29, 2021R
Recruiting
- Melanoma
- Nivolumab
- +2 more
- Philadelphia, PennsylvaniaAbramson Cancer Center at University of Pennsylvania
2021-09-15
Sep 15, 2021I
Active, not recruiting
- COVID19
- +4 more
- Hydroxychloroquine
- Meldola, FC, ItalyIrst Irccs
2021-02-11
Feb 11, 2021D
Recruiting
- Individuals Undergoing Cardiac and General Surgery
- Hydroxychloroquine
- Durham, North CarolinaDuke Health
2021-04-01
Apr 1, 2021H
Completed
- Covid19
- Hydroxychloroquine
- +3 more
- Ankara, Turkey
- +5 more
2021-07-26
Jul 26, 2021C
Terminated
- Respiratory Distress Syndrome, Adult
- COVID-19
- Dexamethasone and Hydroxychloroquine
- Hydroxychloroquine
- Le Plessis-Robinson, FranceReanimation adulte. Hopital Marie Lannelongue
2021-08-06
Aug 6, 2021K
Withdrawn
- SARS-CoV-2 Pneumonia
- COVID-19
- Hydroxychloroquine
- Coeur d'Alene, IdahoKootenai Health
2021-02-04
Feb 4, 2021S
Terminated
- COVID-19
- SARS-CoV 2
- Hydroxychloroquine
- Vitamin D
- Sioux Falls, South DakotaSanford Health
2021-09-21
Sep 21, 2021B
Completed
- COVID-19
- Hydroxychloroquine
- Dallas, TexasBaylor University Medical Center
2021-08-18
Aug 18, 2021U
Recruiting
- Gastrointestinal Neoplasms
- Ulixertinib
- Hydroxychloroquine
- Salt Lake City, UtahHuntsman Cancer Institute
2021-07-15
Jul 15, 2021W
Withdrawn
- Myelodysplastic Syndromes
- Progressive Disease
- CPI-613
- Hydroxychloroquine
- Buffalo, New York
- +1 more
2021-04-08
Apr 8, 2021S
Recruiting
- Prostate Cancer
- SUBA-itraconazole
- Hydroxychloroquine
- Darlinghurst, New South Wales, AustraliaSt Vincent's Hospital
2021-03-02
Mar 2, 2021J
Not yet recruiting
- Healthy
- Nipocalimab
- +2 more
- Groningen, NetherlandsPRA Health Sciences
2021-08-31
Aug 31, 2021C
T
Completed
- Zellweger Syndrome
- Peroxisome Biogenesis Disorders
- Hydroxychloroquine
- Placebo
- Toronto, Ontario, CanadaThe Hospital for Sick Children
2020-12-15
Dec 15, 2020H
Withdrawn
- COVID
- Camostat Mesilate
- +2 more
- (no location specified)
2020-12-17
Dec 17, 2020M
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Binimetinib
- Hydroxychloroquine
- Houston, TexasM D Anderson Cancer Center
2021-03-05
Mar 5, 2021U
Completed
- Multiple Sclerosis, Primary Progressive
- Hydroxychloroquine
- Calgary, Alberta, CanadaMS Clinic Foothills Medical Centre
2021-07-28
Jul 28, 2021A
Not yet recruiting
- Breast Cancer
- Abemaciclib
- Hydroxychloroquine
- Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
2021-10-01
Oct 1, 2021C
Not yet recruiting
- Interstitial Lung Disease
- Surfactant Dysfunction
- Hydroxychloroquine
- Shanghai, Shanghai, ChinaChildren's hospital of Fudan University
2021-07-27
Jul 27, 2021N
Completed
- Congenital Heart Block
- +2 more
- Hydroxychloroquine
- New York, New YorkNew York University School of Medicine
2021-02-04
Feb 4, 2021U
Terminated
- COVID-19
- Hydroxychloroquine
- Placebo
- Tübingen, GermanyInstitute for Tropical Medicine
2020-10-29
Oct 29, 2020